Akanksha Thakkar
@athakkarmd
Interventional Cardiology from @umnews ~ Cardiology from @HMHCardioFellow ~ Nature lover and all things Calvin & Hobbes ~ Here for #CardioEd
ID: 2811724484
15-09-2014 18:09:57
157 Tweet
626 Followers
333 Following
Don’t miss #CVDprevention on Oct 3 with Khurram Nasir! Hear updates on the latest recommendations for #heartdisease #prevention, from #hearthealthy lifestyle interventions to testing and #clinical decision making. #CardioEd #CardioTwitter Sign up: bit.ly/2V9J79N
#EMPEROR-Reduced: Empagliflozin vs placebo in #heartfailure with reduced ejection fraction #ESCCongress 👏👏👏 Preliminary results vs DAPA-HF Treatment in HFrEF Soc Esp Cardiología Shelley Zieroth Paola Beltran Tronco Mihai Trofenciuc Dr Anastasia Mihailidou FAHA FCSANZ FESC rafavidalperez Gregg Fonarow MD Mamas A. Mamas
EMPEROR reduced: Empagliflozine ‼️ ⬇️ 25% CV death or HHF (regardless of the presence or absence of diabetes) ‼️⬇️ 30% HHF ‼️Annual rate of decline in GFR rate was slower (–0.55 vs. –2.28 ml per minute) nejm.org/doi/full/10.10… #ESCCongress Soc Esp Cardiología
#ESCCongress #EVAPORATE result being presented now! Matthew Budoff MD ♥️Study designed to look at effect of EPA on plaque progression using CTA at baseline/9m/18m vs placebo ♥️Small study size but powered to assess endpoint ♥️Significant reduction in plaque quantity in EPA vs placebo
EXPLORER-HCM, hot line @ #ESCCongress 2020: Antimyosin drug mavacamten in symptomatic HOCM over 30 wks lowers gradients and achieves primary endpoint (NHYA improved and/or pVO2 up) in 37% (mavacamten) vs. 17% (placebo) Exploratory endpt.: 27% symptom-free European Society of Cardiology #cardiotwitter
49 yo 🧔🏻 w/ STEMI, how would you treat? PCRonline 🫀 Salvatore Brugaletta MIЯVΛƬ #IC ༄ 。° Aaysha Cader Tom Johnson Guillaume Bonnet t.ozan🦅🐈👶🏻 Victoria Johnson Ümit Yaşar Sinan, MD, FESC Ismail Polat Canbolat Evandro Martins F. MD María Rubini ainhoape Süleyman Çağan Efe Chadi Alraies, MD FACC FSCAI Ali A. Elzieny European Society of Cardiology Mert İlker Hayıroğlu Tufan Çınar
Akanksha Thakkar Women As One MIЯVΛƬ #IC ༄ 。° Sabeeda Kadavath Lina Ya’Qoub MD Anuradha Tunuguntla MD FACC FSCAI Sena Kilic, MD, FACC Poonam Velagapudi Hyeon-Ju (HJ) Ali, MD Shubha Deep Roy, MD, FACC, FASE, FASNC, FSCAI Isaac Tea Hasan Rehman @scfuentesr Priyanka Satish @prkothapalli Kimberly Atianzar MD FACC FASE Ada C. Stefanescu Schmidt, MD MSc FACC Tasleem Katchi Aaysha Cader Collimation - done much too little. Linear reduction of dose and even what feels like collimating just a little oftenm covers half of the area of the field of view. One debated aspect is "steep angulations" Just a few degree of angulations will double the dose.
Akanksha Thakkar Women As One MIЯVΛƬ #IC ༄ 。° Sabeeda Kadavath Lina Ya’Qoub MD Anuradha Tunuguntla MD FACC FSCAI Sena Kilic, MD, FACC Poonam Velagapudi Hyeon-Ju (HJ) Ali, MD Shubha Deep Roy, MD, FACC, FASE, FASNC, FSCAI Isaac Tea Hasan Rehman @scfuentesr Priyanka Satish @prkothapalli Kimberly Atianzar MD FACC FASE Ada C. Stefanescu Schmidt, MD MSc FACC Tasleem Katchi Aaysha Cader But steep angulations are si metimes necessary to really see what you need to see. So chose angulations wisely and do not do unnecessary ones. Important also frame rate! 7.5 frames/s is absolutely enough for coronary work.
Live in 1H! Join us for this week's #GrandRounds Conference featuring Akanksha Thakkar and Isaac Tea! Houston Methodist CV #MedEd #CardioEd #CardioTwitter Watch it Live @ bit.ly/32PCm06
We celebrated our 2021 Cardiology Fellowships Graduation & Awards Ceremony this past Friday. 💙🥳 Check out this special cameo from Dr. Glaucomflecken (Dr. Glaucomflecken)! ⏩vimeo.com/558073249 #hmhfellow @ACCFIT #congratsgrads #Graduation2021 Houston Methodist Residency & Fellowship Programs Houston Methodist CV